98 related articles for article (PubMed ID: 7102672)
1. Initial management of lupus glomerulonephritis.
Knutson DW
Am J Kidney Dis; 1982 Jul; 2(1 Suppl 1):229-36. PubMed ID: 7102672
[No Abstract] [Full Text] [Related]
2. Monthly plasmapheresis for systemic lupus erythematosus with diffuse proliferative glomerulonephritis: a pilot study.
Clark WF; Lindsay RM; Cattran DC; Chodirker WB; Barnes CC; Linton AL
Can Med Assoc J; 1981 Jul; 125(2):171-4. PubMed ID: 7272867
[TBL] [Abstract][Full Text] [Related]
3. Plasmapheresis for the treatment of severe lupus nephritis: uncontrolled observations.
Lewis EJ
Am J Kidney Dis; 1982 Jul; 2(1 Suppl 1):182-7. PubMed ID: 7102667
[No Abstract] [Full Text] [Related]
4. Lupus nephritis.
Johns Hopkins Med J; 1982 Mar; 150(3):101-6. PubMed ID: 7062572
[No Abstract] [Full Text] [Related]
5. [Initial plasmapheresis treatment results in glomerulonephritis].
Nenov D; Stanchev I; Chankova P
Vutr Boles; 1981; 20(2):105-8. PubMed ID: 7257329
[TBL] [Abstract][Full Text] [Related]
6. The application of plasmapheresis in systemic lupus erythematosus.
Jones JV
Prog Clin Biol Res; 1982; 106():81-9. PubMed ID: 6817336
[No Abstract] [Full Text] [Related]
7. [Plasmapheresis in the treatment of immunological nephropathies].
Frasca' G; Vangelista A; Nanni Costa A; Cucudis P
G Clin Med; 1981 Apr; 62(4):260-9. PubMed ID: 7021294
[No Abstract] [Full Text] [Related]
8. Apheresis is of no value in SLE.
Hunsicker LG
Trans Am Soc Artif Intern Organs; 1984; 30():697-9. PubMed ID: 6533963
[No Abstract] [Full Text] [Related]
9. Overview of treatment of lupus nephropathy.
Coggins CH
Am J Kidney Dis; 1982 Jul; 2(1 Suppl 1):197-200. PubMed ID: 7102668
[No Abstract] [Full Text] [Related]
10. Systemic lupus erythematosus V: lupus nephritis.
Blotzer JW
Md State Med J; 1983 Nov; 32(11):851-6. PubMed ID: 6361395
[No Abstract] [Full Text] [Related]
11. [Plasmapheresis in human therapeutics].
Kennes B
Rev Med Brux; 1983 Dec; 4(10):649-57. PubMed ID: 6658248
[No Abstract] [Full Text] [Related]
12. [Secondary glomerular nephropathies].
Lesavre P
Rev Prat; 2003 Nov; 53(18):2039-48. PubMed ID: 15008219
[TBL] [Abstract][Full Text] [Related]
13. [Plasmapheresis in treating circulating immune complex diseases].
Geavlete A; Viorel D
Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1985; 37(4):377-83. PubMed ID: 2865800
[No Abstract] [Full Text] [Related]
14. Plasmapheresis in hereditary angioneurotic edema and systemic lupus erythematosus.
Young DW; Thompson RA; Mackie PH
Arch Intern Med; 1980 Jan; 140(1):127-8. PubMed ID: 7352788
[TBL] [Abstract][Full Text] [Related]
15. [Indications for the application of plasmapheresis (author's transl)].
Samtleben W; Blumenstein M; Habersetzer R; Gurland HJ
MMW Munch Med Wochenschr; 1982 Jul; 124(27):641-5. PubMed ID: 6810157
[No Abstract] [Full Text] [Related]
16. Therapeutic plasmapheresis; present state and future aspects.
Gurland HJ; Samtleben W; Blumenstein M
Life Support Syst; 1983; 1(1):61-70. PubMed ID: 6379316
[No Abstract] [Full Text] [Related]
17. [Morphological and immunohistochemical characteristics of nephropathies in systemic lupus erythematosus].
Tareeva IE; Potekaeva MA; Varshavskiĭ VA
Ter Arkh; 1968 Aug; 40(8):60-6. PubMed ID: 4194899
[No Abstract] [Full Text] [Related]
18. Systemic lupus erythematosus XII: Cytotoxic therapy and pheresis.
Stevens MB
Md State Med J; 1984 Jul; 33(7):538-40. PubMed ID: 6381919
[No Abstract] [Full Text] [Related]
19. Lupus glomerulonephritis. Short review and guide to therapy.
Fialkow RZ; Lee SM
Ariz Med; 1978 May; 35(5):338-41. PubMed ID: 655881
[No Abstract] [Full Text] [Related]
20. [Clinical study on therapeutic plasmapheresis--mechanism of its efficacy, indications, and clinical application. b. Removal of antigen-antibody complex and clinical indications].
Shiokawa Y
Nihon Rinsho; 1984 Aug; 42(8):1861-5. PubMed ID: 6392609
[No Abstract] [Full Text] [Related]
[Next] [New Search]
